Forschungsinstitut für Molekulare Pathologie GmbH (IMP): public contracts won
Forschungsinstitut für Molekulare Pathologie GmbH (IMP) won 10 public contract awards from 4 public buyers between 2024-08-19 and 2026-03-23; the 4 it won alone that state a value total €14.2M. Source: Arcadium Data, data as of .
Awards per month
Contract award notices naming Forschungsinstitut für Molekulare Pathologie GmbH (IMP) as a winner, by publication month, 2023-11 to 2026-10.
Top public buyers
| Buyer | Awards |
|---|---|
| GMI — Gregor Mendel Institut für Molekulare Pflanzenbiologie GmbH | 4 |
| Institut für molekulare Biotechnologie GmbH (IMBA) | 3 |
| Vienna BioCenter Core Facilities GmbH | 2 |
| IMBA - Institut für molekulare Biotechnologie GmbH | 1 |
Sectors (CPV divisions)
| Sector | CPV | Awards |
|---|---|---|
| Research and development | 73 | 10 |
Buyer countries
| Country | Awards |
|---|---|
| Austria | 10 |
Recent awards
Value = the awarded value the notice states, in EUR (converted at the notice date). A notice with several winners or lots states one total for all of them: it is shown per notice in the table but left out of "value won alone". Grouped by company name and winner country; not matched to a website yet.
Track public contracts
Get every new call for tender and contract award in your sectors and countries, keyed by winner domain: a daily feed, the REST API and an MCP server for AI agents. Free to start, no card.
Source: Arcadium Data tenders database, 3,362,786 official public procurement notices from EU TED and UK Find a Tender, read through their open-data APIs (no logins). Winners that could be a private person (sole traders) are withheld; buyers are public bodies. Data as of 2026-10-23.
Questions
How many public contracts has Forschungsinstitut für Molekulare Pathologie GmbH (IMP) won?
Forschungsinstitut für Molekulare Pathologie GmbH (IMP) won 10 public contract awards published between 2024-08-19 and 2026-03-23, from 4 public buyers (official notices in EU TED and UK Find a Tender, as of 2026-10-23).
Who are Forschungsinstitut für Molekulare Pathologie GmbH (IMP)'s biggest public-sector customers?
The public buyers that awarded Forschungsinstitut für Molekulare Pathologie GmbH (IMP) the most contracts are GMI — Gregor Mendel Institut für Molekulare Pflanzenbiologie GmbH (4), Institut für molekulare Biotechnologie GmbH (IMBA) (3) and Vienna BioCenter Core Facilities GmbH (2) (awards, as of 2026-10-23).
What does Forschungsinstitut für Molekulare Pathologie GmbH (IMP) supply to the public sector?
Most of Forschungsinstitut für Molekulare Pathologie GmbH (IMP)'s awards are in Research and development (CPV 73) (10) as of 2026-10-23.
What is the value of Forschungsinstitut für Molekulare Pathologie GmbH (IMP)'s public contracts?
The 4 awards Forschungsinstitut für Molekulare Pathologie GmbH (IMP) won alone that state a value add up to €14.2M; awards shared with other winners state one total for all and are not counted (as of 2026-10-23).
Cite as: Arcadium Data, "Forschungsinstitut für Molekulare Pathologie GmbH (IMP) public tenders won: 10 contract awards", https://arcadiumdata.io/tenders/winners/forschungsinstitut-fur-molekulare-pathologie-gmbh-im-at/, data as of 2026-10-23.